FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1

F-box and WD repeat domain-containing 7 (FBW7) has been characterized as a tumor suppressor, and its mutation or decreased expression has been observed in many types of human cancers. Our recent studies have uncovered that in pancreatic cancer, the KRAS mutation decreased FBW7 expression through pho...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qiangsheng, Qin, Yi, Zhang, Bo, Liang, Chen, Ji, Shunrong, Shi, Si, Xu, Wenyan, Xiang, Jinfeng, Liang, Dingkong, Ni, Quanxing, Yu, Xianjun, Xu, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652962/
https://www.ncbi.nlm.nih.gov/pubmed/28765935
http://dx.doi.org/10.3892/or.2017.5856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652962/
https://www.ncbi.nlm.nih.gov/pubmed/28765935
http://dx.doi.org/10.3892/or.2017.5856

Ejemplares similares